Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185547,
        author = {DEEPAK PALIWAL and PUTTANNA K.},
        title = {India’s Pharmaceutical Marketing Regulation in the Global Context: Ethics, Enforcement, and Emerging Norms},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {1805-1812},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185547},
        abstract = {As of 2025, India’s pharmaceutical marketing landscape is governed by a multifaceted regulatory framework integrating statutory mandates, self-regulatory codes, judicial oversight, and evolving digital compliance norms. This article presents a comprehensive analysis of the key legislative instruments—including the Drugs and Cosmetics Act, 1940; the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954; and the Consumer Protection Act, 2019—alongside the operational roles of regulatory bodies such as CDSCO, DoP, PCI, and State Drug Controllers. It critically examines the transition of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) from a voluntary to a mandatory regime, highlighting its implications for ethical promotion, CEO accountability, and audit enforcement. The study also explores the intersection of medical ethics, influencer liability, and post-marketing surveillance, supported by recent judicial interventions and industry adaptations. Despite the framework's robustness, enforcement bottlenecks and legislative delays persist, especially in the digital and AYUSH sectors. The article concludes by emphasising the need for sustained vigilance, digital harmonisation, and stakeholder collaboration to uphold ethical standards in India’s rapidly evolving pharmaceutical market.},
        keywords = {Pharmaceutical marketing regulation, UCPMP 2024, Consumer Protection Act 2019, ethical promotion, medical ethics, ASCI guidelines,},
        month = {October},
        }